We compared effects across RICTOR-amplified, RICTOR-diploid, and Rictor protein–overexpressing TNBC models, finding robust mTORC2 inhibition and tumor cell killing in PI3K-active TNBC. The gene discussed is PIK3CA; the disease is neoplasm.